Inhibitory properties of separate recombinant Kunitz-type-protease-inhibitor domains from tissue-factor-pathway inhibitor.
about
Engineering the substrate and inhibitor specificities of human coagulation Factor VIIaStructure of the recombinant BPTI/Kunitz-type inhibitorrShPI-1A from the marine invertebrateStichodactyla helianthusSmall Peptides Blocking Inhibition of Factor Xa and Tissue Factor-Factor VIIa by Tissue Factor Pathway Inhibitor (TFPI)Sequence and conformational specificity in substrate recognition: several human Kunitz protease inhibitor domains are specific substrates of mesotrypsin.Selection of human elastase inhibitors from a conformationally constrained combinatorial peptide library.Three genes expressing Kunitz domains in the epididymis are related to genes of WFDC-type protease inhibitors and semen coagulum proteins in spite of lacking similarity between their protein products.Minimal and inducible regulation of tissue factor pathway inhibitor-2 in human gliomas.Distinct expression pattern of two related human proteins containing multiple types of protease-inhibitory modules.The Kunitz-3 domain of TFPI-alpha is required for protein S-dependent enhancement of factor Xa inhibitionMechanisms and specificity of factor XIa and trypsin inhibition by protease nexin 2 and basic pancreatic trypsin inhibitorEngineering kunitz domain 1 (KD1) of human tissue factor pathway inhibitor-2 to selectively inhibit fibrinolysis: properties of KD1-L17R variantRestoration of tissue factor pathway inhibitor inhibits invasion and tumor growth in vitro and in vivo in a malignant meningioma cell line.Activated factor XI increases the procoagulant activity of the extrinsic pathway by inactivating tissue factor pathway inhibitorNotecarin D binds human factor V and factor Va with high affinity in the absence of membranes.Heparin modulates the 99-loop of factor IXa: effects on reactivity with isolated Kunitz-type inhibitor domains.Platelet-Derived Short-Chain Polyphosphates Enhance the Inactivation of Tissue Factor Pathway Inhibitor by Activated Coagulation Factor XI.Tissue factor pathway inhibitor: structure-function.Natural and engineered plasmin inhibitors: applications and design strategies.Protein anticoagulants targeting factor VIIa-tissue factor complex: a comprehensive review.Recent advances on plasmin inhibitors for the treatment of fibrinolysis-related disorders.Aptamer BAX 499 mediates inhibition of tissue factor pathway inhibitor via interaction with multiple domains of the protein.Comparison of cell-surface TFPIalpha and beta.Characterization of placental bikunin, a novel human serine protease inhibitor.Factor V has an anticoagulant cofactor activity that targets the early phase of coagulation.Fusion proteins comprising annexin V and Kunitz protease inhibitors are highly potent thrombogenic site-directed anticoagulants.Structural and functional characterization of tissue factor pathway inhibitor following degradation by matrix metalloproteinase-8.Recombinant TFPI and variants: potential implications in the treatment of cardiovascular disorders.Pig tissue factor pathway inhibitor α fusion immunoglobulin inhibits pig tissue factor activity in human plasma moderately more efficiently than the human counterpart.Endothelial cell-anchored tissue factor pathway inhibitor regulates tumor metastasis to the lung in mice.Tissue factor pathway inhibitor is highly susceptible to chymase-mediated proteolysis.
P2860
Q27644590-88E4D526-8DFA-4F7B-871E-1287BBFFCCBAQ27675071-012F5EA3-B24B-4410-B315-4AF0E91BF223Q27680684-C15BA79D-51C6-4964-931E-CC478D80A887Q30367678-DD77879B-847B-4F32-B8EB-6DB2B10F93C6Q30812768-1BD46DA3-73B0-43B5-A01B-66052CF52AEDQ31031977-6FC3C689-4D02-4770-9E48-85C885E04872Q34113728-41349DD8-96A9-4302-978D-583AF987544CQ34121607-0C7C92E4-A31F-4105-8CA1-D9EDCCA162E0Q34122695-DDA69E4B-D55A-4B78-AD27-9FA9C46D81C1Q34541270-93FE9478-0763-418F-AF30-8767276E9DECQ34575895-65E5C140-C733-4E0E-A1DE-DEB2AF9CEF73Q34683461-94ED5DFB-7E65-4033-B494-EF992D9EDA19Q35126274-8D9B2061-BF5D-475D-9E88-158CE7E35589Q35516000-548B7E0A-B9F5-4C36-A69E-F43679F677A2Q35723932-E4ADAC4C-5430-4B8D-A5EF-3F5CA9E6C89FQ36169665-BEC02F01-ADD8-4078-BCAE-0462E8540A72Q37971520-A8644AD0-8DAE-4665-98A6-4ADE33EBC2C0Q37975189-37AE41A5-1F1B-43BB-B51A-B94F8A47F429Q38043676-14C66903-FBA5-4D12-AD72-A3AB629046C1Q38198582-40B226B6-4E00-42BE-A204-F75DCD0109E9Q38316749-ED339FC6-83CE-405B-8134-84D61A009AADQ40358543-4EE57AAB-E166-46C0-8DB5-7A92368AFE9CQ41110972-CD1BC20D-BCF1-4617-8B80-8CA159DA7440Q41936652-14E42F13-B719-4D60-A12E-BB9D385195FCQ42742710-0BD44066-62F7-4391-B34B-88A8EE1DD8DFQ43002265-B2826616-6D5A-49B9-B1FA-BA4972EBF36EQ47771140-6102A8D0-0334-4F5D-BC4D-CFCACC0C6940Q48022964-904B3A69-C3C2-48F7-BB75-277243DA7AEEQ50980605-5D3476FD-92E7-4C96-AD60-380749123179Q51797373-D359A33B-A252-408B-910D-AC1D668DA1B7
P2860
Inhibitory properties of separate recombinant Kunitz-type-protease-inhibitor domains from tissue-factor-pathway inhibitor.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Inhibitory properties of separ ...... ssue-factor-pathway inhibitor.
@en
type
label
Inhibitory properties of separ ...... ssue-factor-pathway inhibitor.
@en
prefLabel
Inhibitory properties of separ ...... ssue-factor-pathway inhibitor.
@en
P2093
P2860
P1433
P1476
Inhibitory properties of separ ...... ssue-factor-pathway inhibitor.
@en
P2093
P2860
P304
P356
10.1111/J.1432-1033.1996.0310F.X
P407
P577
1996-01-01T00:00:00Z